Cytotoxic and apoptotic effects of caffeate derivatives on A549 human lung carcinoma cells

Journal of the Chinese Medical Association

Volumn 77, Issue 10, 2014, Pages 535-543

  Chen, Yi Chen ^a   Kuo, Yueh Hsiung ^b,c   Yang, Nae Cherng ^d   Liu, Cheng Wei ^e   Chang, Wei Tang ^d   Hsu, Chin Lin ^d,f  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e MINGDAO UNIVERSITY   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

A549 cells; Apoptosis; Caffeate derivatives; Protein expression

Indexed keywords

CAFFEIC ACID DERIVATIVE; DECYL CAFFEIC ACID; OCTYL CAFFEIC ACID; PHENYLPROPYL CAFFEIC ACID; UNCLASSIFIED DRUG; OCTYL CAFFEATE;

APOPTOSIS; ARTICLE; CANCER CELL LINE; CELL STRUCTURE; CELL VIABILITY; CYTOTOXICITY; HUMAN; HUMAN CELL; LUNG CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; PROPIDIUM IODIDE ASSAY; WESTERN BLOTTING; CELL SURVIVAL; DRUG EFFECTS; LUNG NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CAFFEIC ACIDS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; LUNG NEOPLASMS;

EID: 84908135877     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2014.05.011     Document Type: Article

References (34)

1. Nayak L., Lee E.Q., Wen P.Y. Epidemiology of brain metastases. Curr Oncol Rep 2012, 14:48-54.
2. Pao W., Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 2010, 10:760-774.
3. Škarda J., Hajdúch M., Kolek V. Drug resistance in lung cancer. Cancer Ther 2008, 6:377-388.
4. Burdock G.A. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxic 1998, 36:347-363.
5. da Cunha F.M., Duma D., Assreuy J., Buzzi F.C., Niero R., Campos M.M., et al. Caffeic acid derivatives: invitro and invivo anti-inflammatory properties. Free Radic Res 2004, 38:1241-1253.
6. Uwai K., Osanai Y., Imaizumi T., Kanno S., Takeshita M., Ishikawa M. Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages. Bioorg Med Chem 2008, 16:7795-7803.
7. Ujibe M., Kanno S., Osanai Y., Koiwai K., Ohtake T., Kimura K., et al. Octylcaffeate induced apoptosis in human leukemia U937 cells. Biol Pharm Bull 2005, 28:2338-2341.
8. Fiuza S.M., Gomes C., Teixeira L.J., Girão da Cruz M.T., Cordeiro M.N., Milhazes N., et al. Phenolic acid derivatives with potential anticancer properties-a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids. Bioorg Med Chem 2004, 12:3581-3589.
9. Nagaoka T., Banskota A.H., Tezuka Y., Harimaya Y., Koizumi K., Saiki I., et al. Inhibitory effects of caffeic acid phenethyl ester analogues on experimental lung metastasis of murine colon 26-L5 carcinoma cells. Biol Pharm Bull 2003, 26:638-641.
10. Kudugunti S.K., Vad N.M., Whiteside A.J., Naik B.U., Yusuf M.A., Srivenugopal K.S., et al. Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines. Chem Biol Interact 2010, 188:1-14.
11. Lin C.L., Chen R.F., Chen J.Y., Chu Y.C., Wang H.M., Chou H.L., et al. Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-κB pathway. Int J Mol Sci 2012, 13:6236-6245.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
13. Platt N., da Silva R.P., Gordon S. Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol 1998, 8:365-372.
14. Vattemi E., Claudio P.P. Tumor suppressor genes as cancer therapeutics. Drug News Perspect 2007, 20:511-520.
15. Johnstone R.W., Ruefli A.A., Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002, 108:153-164.
16. Fresco P., Borges F., Marques M.P., Diniz C. The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr Pharm Des 2010, 16:114-134.
17. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
18. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999, 399:483-487.
19. Pandey P., Saleh A., Nakazawa A., Kumar S., Srinivasula S.M., Kumar V., et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 2000, 19:4310-4322.
20. Pan M.H., Chang W.L., Lin-Shiau S.Y., Ho C.T., Lin J.K. Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem 2001, 49:1464-1474.
21. Hsu P.C., Huang Y.T., Tsai M.L., Wang Y.J., Lin J.K., Pan M.H. Induction of apoptosis by shikonin through coordinative modulation of the Bcl-2 family, p27, and p53, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells. J Agric Food Chem 2004, 52:6330-6337.
22. Roy A.M., Baliga M.S., Katiyar S.K. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther 2005, 4:81-90.
23. Zlobec I., Vuong T., Compton C.C. The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative high dose rate brachytherapy. Cancer 2006, 106:284-286.
24. Fulda S. Caspase-8 in cancer biology and therapy. Cancer Lett 2009, 281:128-133.
25. Nagata S., Golstein P. The Fas death factor. Science 1995, 267:1449-1456.
26. Tschopp J., Irmler M., Thome M. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 1998, 10:552-558.
27. Yu J.W., Shi Y. FLIP and the death effector domain family. Oncogene 2008, 27:6216-6227.
28. Szegezdi E., Fitzgerald U., Samali A. Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann NY Acad Sci 2003, 1010:186-194.
29. Lorenzo H.K., Susin S.A. Therapeutic potential of AIF-mediated caspase independent programmed cell death. Drug Resist Updat 2007, 10:235-255.
30. Zhou Z.Y., Yang G.Y., Zhou J., Yu M.H. Significance of TRIM29 and β-catenin expression in non-small-cell lung cancer. J Chin Med Assoc 2012, 75:269-274.
31. Hsiao G., Shen M.Y., Chang W.C., Cheng Y.W., Pan S.L., Kuo Y.H., et al. Anovel antioxidant, octyl caffeate, suppression of LPS/IFN-gamma-induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells. Biochem Pharmacol 2003, 65:1383-1392.
32. Chou Y.C., Sheu J.R., Chung C.L., Chen C.Y., Lin F.L., Hsu M.J., et al. Nuclear-targeted inhibition of NF-kappaB on MMP-9 production by N-2-(4-bromophenyl) ethyl caffeamide in human monocytic cells. Chem Biol Interact 2010, 184:403-412.
33. Weng Y.C., Chuang C.F., Chuang S.T., Chiu H.L., Kuo Y.H., Su M.J. KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart. Eur J Pharmacol 2012, 684:108-115.
34. Ho Y.J., Chen W.P., Chi T.C., Chang Chien C.C., Lee A.S., Chiu H.L., et al. Caffeic acid phenethyl amide improves glucose homeostasis and attenuates the progression of vascular dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetol 2013, 12:99.